New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 13, 2014
11:44 EDTESRXExpress Scripts repeats FY14 adjusted EPS view $4.82-$4.94, consensus $4.87
Repeats FY14 adjusted EBITDA view $6.775B-$6.975B. Sees FY14 adjusted EBITDA per adjusted claim $5.20-$5.30. Sees FY14 EPS growth of 17%-20% excluding UNH. Sees FY14 adjusted claims 1.27B-1.33B. Comments from slides that are being presented at the Bank of America Merrill Lynch Healthcare Conference.
News For ESRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 16, 2014
08:22 EDTESRXExpress Scripts CFO change a 'modest' concern, says Leerink
Subscribe for More Information
07:47 EDTESRXExpress Scripts new CFO experience reassuring, says Oppenheimer
Subscribe for More Information
December 15, 2014
16:40 EDTESRXExpress Scripts backs FY14 EPS view $4.86-$4.90, consensus $4.88
Subscribe for More Information
16:39 EDTESRXExpress Scripts increases share repurchase authorization by 65M shares
Subscribe for More Information
16:37 EDTESRXExpress Scripts CFO Cathy Smith leaving company
Subscribe for More Information
07:40 EDTESRXExpress Scripts price target raised to $96 from $82 at UBS
Subscribe for More Information
December 8, 2014
11:30 EDTESRXLeerink generics pharmaceutical analyst holds analyst/industry conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use